小费
发表于 2025-3-21 18:23:40
书目名称Handbook of Chronic Myeloid Leukemia影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0420990<br><br> <br><br>书目名称Handbook of Chronic Myeloid Leukemia读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0420990<br><br> <br><br>
glowing
发表于 2025-3-21 23:46:18
http://reply.papertrans.cn/43/4210/420990/420990_2.png
entreat
发表于 2025-3-22 01:43:55
Book 2014d provides an authoritative and convenient summary of the latest progress in TKI trials, the molecular monitoring of CML responses, and the development of new therapies to overcome resistance and improve patient care. Chronic myeloid leukemia (CML) is a rare type of leukemia (1–2 per 100,000 people)
Redundant
发表于 2025-3-22 06:58:29
http://reply.papertrans.cn/43/4210/420990/420990_4.png
系列
发表于 2025-3-22 09:55:24
http://reply.papertrans.cn/43/4210/420990/420990_5.png
娴熟
发表于 2025-3-22 15:50:13
http://reply.papertrans.cn/43/4210/420990/420990_6.png
矛盾
发表于 2025-3-22 17:31:33
http://reply.papertrans.cn/43/4210/420990/420990_7.png
推延
发表于 2025-3-23 01:08:06
http://reply.papertrans.cn/43/4210/420990/420990_8.png
显示
发表于 2025-3-23 02:55:35
Fiction: A Screenplay-to-Understanding,When a patient presents with suspected chronic myeloid leukemia (CML) appropriate assessments are needed to confirm the diagnosis and stage of disease, and to assign a risk score to that patient.
柱廊
发表于 2025-3-23 08:51:44
A Brief Note on Looking Forward,Resistance to tyrosine kinase inhibitors (TKIs) can be defined on the basis of its time of onset. Primary resistance is a failure to achieve a significant therapeutic response, whereas secondary or acquired resistance is the progressive reappearance of the leukemic clone after an initial response to the drug.